# Study Evaluating PPM-204 In Subjects With Type 2 Diabetes

> **NCT00425919** · PHASE2 · TERMINATED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 500 (—)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** PPM-204

## Key facts

- **NCT ID:** NCT00425919
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 500 (—)
- **Why stopped:** Study terminated as a result of interim analysis not meeting predetermined criteria.
- **Last updated:** 2007-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00425919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00425919, "Study Evaluating PPM-204 In Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00425919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*